Oncology Clinical Trials in Boise, ID
As of August 2026, 46 paid clinical trials are recruiting for Oncology in Boise, Idaho. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
46 clinical trials for Oncology
·Clear filters·Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)
A Study of Navlimetostat (BMS-986504) in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion (MountainTAP-9)
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Cost Communication and Financial Navigation in Cancer Patients (COSTCOM)
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
Evaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors
Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Project: Every Child for Younger Patients With Cancer
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
Top Research Study Locations in Boise
Researchers run research studies in Boise, ID at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Saint Luke's Cancer Institute - Boise | Acute Myeloid Leukemia, Malignant Solid Neoplasm, Anatomic Stage II Breast Cancer AJCC v8 | 78 |
| Saint Alphonsus Cancer Care Center-Boise | Acute Myeloid Leukemia, Stage IV Lung Cancer AJCC v8, Recurrent Lung Non-Small Cell Carcinoma | 57 |
| St. Luke's Boise Medical Center | ARDS, ARDS (Acute Respiratory Distress Syndrome), Acute Respiratory Distress Syndrome | 6 |
| Treasure Valley Medical Research | Atopic Dermatitis, Chronic Idiopathic Constipation (CIC), Chronic Inducible Urticaria | 6 |
| Saint Alphonsus Regional Medical Center | Amyotrophic Lateral Sclerosis, Colonic Diseases, Colorectal Neoplasms | 4 |
| ASR, LLC | Pneumococcal Disease, Healthy, Alopecia Areata | 4 |
| Boise VA Medical Center | Chronic Obstructive Pulmonary Disease, HIV, Inhaled Corticosteroid | 3 |
| Consultants in Epilepsy & Neurology, PLLC | Focal Epilepsy, Epilepsy, Focal Seizure | 3 |
| Consultants in Epilepsy and Neurology, PLLC | Epilepsy, Focal Epilepsy, Focal Onset Seizure | 3 |
| St. Luke's Cancer Institute: Boise | Carcinoma, Transitional Cell, Metastatic Non-small Cell Lung Cancer With MTAP Deletion, Neoplasm Metastasis | 3 |
| Advanced Specialty Research | Idiopathic Overactive Bladder, Idiopathic Overactive Bladder With Urinary Incontinence, Mixed Urinary Incontinence | 2 |
| Ascendis Investigational Site | Growth Hormone Deficiency | 2 |
| Boise VA Medical Center, Boise, ID | BARD1, BRCA1, BRCA2, BRIP1, CHEK1, FANCL, PALB2, Chronic Pain, Metastatic Castrate Resistant Prostate Cancer | 2 |
| GSK Investigational Site | Pulmonary Disease, Chronic Obstructive | 2 |
| Northwest Clinical Trials, Inc. | Actinic Keratosis, Migraine | 2 |
| Saint Alphonsus Regional Medical Center - Boise | Atrial Fibrillation, Intracerebral Hemorrhage, Non-small Cell Lung Cancer | 2 |
| Saint Luke's Cystic Fibrosis Center of Idaho | Cystic Fibrosis, Cystic Fibrosis Pulmonary Exacerbation | 2 |
| St. Alphonsus Regional Medical Center | Aortic Stenosis, Brain Tumor, Brain Tumor - Metastatic | 2 |
| Summit Hyperbarics and Wellness | PTSD - Post Traumatic Stress Disorder, Post Concussive Syndrome, Post-Concussive Symptoms | 2 |
| Saint Alphonsus Regional Medical Center | Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Colon Adenocarcinoma | 2 |
| ASR Idaho CGI | HPV, HPV - Anogenital Human Papilloma Virus Infection | 1 |
| AURORA-1 Clinical Site | Chronic Weight Management, Obesity, Overweight | 1 |
| AURORA-2 Clinical Site | Chronic Weight Management, Obesity, Overweight | 1 |
| Boise State University | Distress, Emotional | 1 |
| Boise, Idaho Investigative | Acute Heart Failure, Heart Failure | 1 |
Active & Upcoming Studies in Boise (2026)
Recruiting trials in Boise grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (99 active studies)
- Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations · Phase 3 · SWOG Cancer Research Network
- Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL · Phase 3 · Alliance for Clinical Trials in Oncology
Neurology & pain (11 active studies)
- Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1 · Phase 3 · Rapport Therapeutics Inc.
- A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT). · Phase 3 · Eli Lilly and Company
Diabetes & metabolic (7 active studies)
- A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes · Phase 3 · Ascletis Pharma (China) Co., Limited
- A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities · Phase 3 · Ascletis Pharma (China) Co., Limited
Cardiovascular (7 active studies)
- Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System · Boston Scientific Corporation
- A Registry Based Collaborative to Measure Efficiency, Effectiveness, and Safety of Farapulse PFA Technology for AF · Heart Rhythm Clinical and Research Solutions, LLC
Vaccines (4 active studies)
Mental health & behavior (2 active studies)
- Optimizing Medications and Lung Health in People With HIV Through Pharmacist-led Proactive E-Consults · Seattle Institute for Biomedical and Clinical Research
- Veterans' Cognitive Function, Mental Health, and Quality of Life After Hyperbaric Oxygen Therapy · Phase 2 · Summit Hyperbarics and Wellness
HIV / STI (1 active study)
- Optimizing Medications and Lung Health in People With HIV Through Pharmacist-led Proactive E-Consults · Seattle Institute for Biomedical and Clinical Research
Common conditions studied in Boise
- Acute Myeloid Leukemia (8 active studies)
- ARDS (5 active studies)
- Acute Respiratory Distress Syndrome (5 active studies)
- Focal Epilepsy (5 active studies)
- Malignant Solid Neoplasm (5 active studies)
- Stage IV Lung Cancer AJCC v8 (5 active studies)
Leading research sponsors in Boise
- National Cancer Institute (NCI)
- SWOG Cancer Research Network
- Alliance for Clinical Trials in Oncology
- Children's Oncology Group
- ECOG-ACRIN Cancer Research Group
Frequently asked questions
How many paid clinical trials are currently recruiting in Boise?
There are approximately 209 recruiting clinical trials in Boise, Idaho listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Boise pay participants?
Most recruiting trials in Boise compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Boise?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Boise?
The most common conditions under active study in Boise include Acute Myeloid Leukemia (8), ARDS (5), Acute Respiratory Distress Syndrome (5), Focal Epilepsy (5), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Boise?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Boise on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Boise?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Boise?
Recruiting research sites in Boise include Saint Luke's Cancer Institute - Boise, Saint Alphonsus Cancer Care Center-Boise, St. Luke's Boise Medical Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Boise right now?
The largest active categories in Boise are Cancer & tumors (99), Neurology & pain (11), Diabetes & metabolic (7). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.